Institut Bergonié
Envoyer Imprimer PDF

publications originales


Publications originales, revues, éditoriaux, conférences

Articles originaux

André F, Bachelot T, Commo F, Campone M, Arnedos M, Dieras V, Lacroix-Triki M, Lacroix L, Cohen P, Gentien D, Adelaide J, Dalenc F, Goncalves A, Levy C, Ferrero JM, Bonneterre J, Lefeuvre C, Jimenez M, Filleron T, Bonnefoi H. Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER). Lancet Oncol 2014 ; 15 : 267-74 (IF : 24.725, SIGAPS : A).

Bonnefoi H, Jacot W, Saghatchian M, Moldovan C, Venat-Bouvet L, Zaman K, Matos E, Petit T, Bodmer A, Quénel-Tueux N, Chakiba C, Vuylsteke P, Jerusalem G, Brain E, Tredan O, Messina CG, Slaets L,  Cameron D. Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study. Ann Oncol 2014 ; Epub 2014 Dec 1 doi: 10.1093/annonc/mdu551 (IF : 6.578, SIGAPS : A).

Bonnefoi H, Litière S, Piccart M, MacGrogan G, Fumoleau P, Brain E, Petit T, Rouanet P, Jassem J, Moldovan C, Bodmer A, Zaman K, Cufer T, Campone M, Luporsi E, Malmstrom P, Werutsky G, Bogaerts J, Bergh J, Cameron DA, on behalf of the EORTC 10994/BIG 1-00 Study Investigators. Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial. Ann Oncol 2014 ; 25 : 1128-36 (IF : 6.578, SIGAPS : A).

Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, Bonnefoi H, Cameron D, Gianni L, Valagussa P, Swain SM, Prowell T, Loibl S, Wickerham DL, Bogaerts J, Baselga J, Perou C, Blumenthal G, Blohmer J, Mamounas EP, Bergh J, Semiglazov V, Justice R, Eidtmann H, Paik S, Piccart M, Sridhara R, Fasching PA, Slaets L, Tang S, Gerber B, Geyer CE, Jr., Pazdur R, Ditsch N, Rastogi P, Eiermann W, von Minckwitz G. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 2014 ; 384 : 164-72 (IF : 39.207, SIGAPS : A).

Franchet C, Filleron T, Cayre A, Mounié E, Penault-Llorca F, Jacquemier J, MacGrogan G, Arnould L, Lacroix-Triki M. Instantquality fluorescence in-situ hybridization as a new tool for HER2 testing in breast cancer: a comparative study. Histopathology 2014 ; 64 : 274-83 (IF : 3.301, SIGAPS : C).

Le Morvan V, Litière S, Laroche-Clary A, Ait-Ouferoukh S, Bellott R, Messina C, Cameron D, Bonnefoi H, Robert J. Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial. Pharmacogenomics J 2014 ; doi: 10.1038/tpj.2014.24. Epub 2014 Jun 24 (IF : 5.513, SIGAPS : A).

Verbeke S, Richard E, Monceau E, Schmidt X, Rousseau B, Velasco V, Bernard D, Bonnefoi H, MacGrogan G, Iggo R. Humanization of the mouse mammary gland by replacement of the luminal layer with geneticallyengineered preneoplastic human cells. Breast Cancer Res 2014 ; 16 : 504. doi: 10.1186/ s13058-014-0504-9 (IF : 5.881, SIGAPS : B).

Chakiba C, Lagarde P, Pissaloux D, Neuville A, Brulard C, Pérot G, Coindre JM, Terrier P, Ranchère-Vince D, Ferrari A, Collini P, Suurmeijer AJH, Blay JY, Aarab-Terrisse S, Piperno-Neumann S, Averous G, Bui BN, Orbach D, Italiano A, Chibon F. Response to chemotherapy is not related to chromosome instability in synovial sarcoma. Ann Oncol 2014 ; 25 : 2267-71 (IF : 6.578, SIGAPS : A).

Cohen-Gogo S, Cellier C, Coindre JM, Mosseri V, Pierron G, Guillemet C, Italiano A, Brugieres L, Orbach D, Laurence V, Delattre O, Michon J. Ewing-like sarcomas with BCOR-CCNB3 fusion transcript: a clinical, radiological and pathological retrospective study from the Société Française des Cancers de L’Enfant. Pediatr Blood Cancer 2014 ; 61 : 2191-8 (IF : 2.562, SIGAPS : C).

Gits CM, van Kuijk PF, Jonkers MB, Boersma AW, Smid M, van Ijcken WF, Coindre JM, Chibon F, Verhoef C, Mathijssen RH, den Bakker MA, Verweij J, Sleijfer S, Wiemer EA. MicroRNA expression profiles  distinguish liposarcoma subtypes and implicate miR-145 AND miR-451 as tumor suppressors. Int J Cancer 2014 ; 135 : 348-61 (IF : 5.007, SIGAPS : B).

Karanian M, Pérot G, Coindre JM, Chibon F, Pedeutour F, Neuville A. Fluorescence in situ hybridization analysis is a helpful test for the diagnosis of dermatofibrosarcoma protuberans. Mod Pathol 2014 ; doi: 10.1038/modpathol.2014.97. Epub 2014 Aug 1 (IF : 6.364, SIGAPS : A).

Le Guellec S, Chibon F, Ouali M, Pérot G, Decouvelaere AV, Robin YM, Larousserie F, Terrier P, Coindre JM, Neuville A. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas? Am J Surg Pathol 2014 ; 38 : 293-304 (IF : 4.592, SIGAPS : A).

Le Loarer F, Zhang L, Fletcher CD, Ribeiro A, Singer S, Italiano A, Neuville A, Houlier A, Chibon F, Coindre JM, Antonescu CR. Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material. Genes Chromosomes Cancer 2014 ; 53 : 475-86 (IF : 3.836, SIGAPS : C).

Neuville A, Chibon F, Coindre JM. Grading of soft tissue sarcomas : from histological to molecular assessment. Pathology 2014 ; 46 : 113-20 (IF : 2.62, SIGAPS : C).

Neuville A, Collin F, Bruneval P, Parrens M, Thivolet F, Gomez-Brouchet A, Terrier P, Thomas de Montpreville T, Le Gall F, Hostein I, Lagarde P, Chibon F, Coindre JM. Intimal sarcoma is the most common primary cardiac sarcoma: clinicopathologic and molecular study of 100 primary cardiac sarcomas. Am J Surg Pathol 2014 ; 38 : 461-9 (IF : 4.592, SIGAPS : A).

Pérot G, Mendiboure J, Brouste V, Velasco V, Terrier P, Bonvalot S, Guillou L, Ranchère-Vince D, Aurias A, Coindre JM, Chibon F. Smooth muscle differentiation identifies two classes of poorly differentiated pleomorphic sarcomas with distinct outcome. Mod Pathol 2014 ; 27 : 840-50 (IF : 6.364, SIGAPS : A).

Skubitz KM, Skubitz AP, Xu WW, Luo X, Lagarde P, Coindre JM, Chibon F. Gene expression identifies heterogeneity of metastatic behavior among high-grade non-translocation associated soft tissue sarcomas. J Transl Med 2014 ; 12 : 176 (IF : 3.991, SIGAPS : B).

Toulmonde M, Bonvalot S, Ray-Coquard I, Stoeckle E, Riou O, Isambert N, Bompas E, Penel N, Delcambre-Lair C, Saada E, Le Cesne A, Le Péchoux C, Blay JY, Piperno-Neumann S, Chevreau C, Bay JO, Brouste V, Terrier P, Ranchère-Vince D, Neuville A, Italiano A. Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol 2014 ; 25 : 730-4 (IF : 6.578, SIGAPS : A).

Wozniak A, Rutkowski P, Schöffski P, Ray-Coquard I, Hostein I, Schildhaus HU, Le Cesne A, Bylina E, Limon J, Blay JY, Siedlecki JA, Wardelmann E, Sciot R, Coindre JM, Debiec-Rychter M. Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: A European multicenter analysis based on ConticaGIST. Clin Cancer Res 2014 ; 20 : 6105-16 (IF : 8.193, SIGAPS : A).

Bécouarn Y, Cany L, Pulido M, Beyssac R, Texereau P, Le Morvan V, Béchade D, Brunet R, Aitouferoukh S, Lalet C, Mathoulin- Pélissier S, Fonck M, Robert J. FOLFIRI® and Bevacizumab in firstline treatment for colorectal cancer patients: safety, efficacy and genetic polymorphisms. BMC Res Notes 2014 ; 7 : 260.

Bourdel-Marchasson I, Blanc-Bisson C, Doussau A, Germain C, Blanc JF, Dauba J, Lahmar C, Terrebonne E, Lecaille C, Ceccaldi J, Cany L, Lavau-Denes S, Houédé N, Chomy F, Durrieu J, Soubeyran P, Senesse P, Chêne G, Fonck M. Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial. PLoS One 2014 ; 9 : e108687 (IF : 3.534, SIGAPS : B).

Boyer JC, Etienne-Grimaldi MC, Thomas F, Quaranta S, Picard N, Loriot MA, Poncet D, Gagnieu MC, Ged C, Broly F, Le Morvan V, Bouquie R, Gaub MP, Philibert L, Ghiringhelli F, Le Guellec C. Intérêt du génotypage de l’UGT1A1 dans le cadre du traitement des cancers digestifs par irinotécan. Bull Cancer 2014 ; 101 : 533-53 (IF : 0.635, SIGAPS : E).

Chodoeva A, Bosc JJ, Lartigue L, Guillon J, Auzanneau C, Costet P, Zurdinov A, Jarry C, Robert J. Antitumor activity of semisynthetic derivatives of Aconitum alkaloids. Invest New Drugs 2014 ; 32 : 60-7 (IF : 2.927, SIGAPS : C).

Dubois J, Etienne G, Laroche-Clary A, Lascaux A, Bidet A, Lippert E, Ait-Ouferoukh S, Saada V, Micol JB, Bouabdallah K, Robert J. Identification of methylguanine methyltransferase polymorphisms as genetic markers of individual susceptibility to therapy-related myeloid neoplasms. Eur J Cancer 2014 ; 50 : 418-24 (IF : 4.819, SIGAPS : B).

Fabre AL, Colotte M, Luis A, Tuffet S, Bonnet J. An efficient method for long-term room temperature storage of RNA. Eur J Hum Genet 2014 ; 22 : 379-85 (IF : 4.225, SIGAPS : B).

Falandry C, Krakowski I, Curé H, Carola E, Soubeyran P, Guerin O, Freyer G. Granulocyte-colony-stimulating factor in elderly patients receiving chemotherapy for breast and gynaecological cancers: results of a French survey. Anticancer Res 2014 ; 34 : 5007-15 (IF : 1.872, SIGAPS : D).

Gallouet AS, Travert M, Bresson-Bepoldin L, Guilloton F, Pangault C, Caulet-Maugendre S, Lamy T, Tarte K, Guillaudeux T. COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosis. Clin Cancer Res 2014 ; 20 : 2663-73 (IF : 8.193, SIGAPS : A).

Houédé N, Pulido M, Mourey L, Joly F, Ferrero JM, Bellera C, Priou F, Lalet C, Laroche-Clary A, Canal Raffin M, Ichas F, Puech A, Piazza PV. A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer. The Oncologist 2014 ; 19 : 1227-8 (IF : 4.54, SIGAPS : B). Publication FAVE

Le Morvan V, Litière S, Laroche-Clary A, Ait-Ouferoukh S, Bellott R, Messina C, Cameron D, Bonnefoi H, Robert J. Identification of SNPs associated with response of breast cancerpatients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial. Pharmacogenomics J 2014 ; doi: 10.1038/tpj.2014.24. Epub 2014 Jun 24 (IF : 5.513, SIGAPS : A).

Mhadhebi L, Mhadhebi A, Robert J, Bouraoui A. Antioxidant, antiinflammatory and antiproliferative effects of aqueous extracts of three Mediterranean brown seaweeds of the genus Cystoseira. Iran J Pharm Res 2014 ; 13 : 207-20.
Michallet M, Luporsi E, Soubeyran P, Amar NA, Boulanger V, Carreiro M, Dourthe LM, Labourey JL, Lepille D, Maloisel F, Mouysset JL, Nahon S, Narciso B, Nouyrigat P, Radji R, Sakek N, Albrand H. BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study. BMC Cancer 2014 ; 14 : 503 (IF : 3.319, SIGAPS : C).

Moghtit FZ, Aberkane MS, Le Morvan V, Louhibi L, Bellot R, Bousahba A, Megaiz A, Fodil M, Mediene-Benchekor S, Zemani-Fodil F, Boudjema A, Robert J, Saidi-Mehtar N. No association between XRCC3 Thr241Met and XPD Lys751Gln polymorphisms and the risk of colorectal cancer in West Algerian population: a case-control study. Med Oncol 2014 ; 31 : 942 (IF : 2.058, SIGAPS : D).

Pérot G, Soubeyran I, Ribeiro A, Bonhomme B, Savagner F, Boutet-Bouzamondo N, Hostein I, Bonichon F, Godbert Y, Chibon F. Identification of a recurrent STRN/ALK fusion in thyroid carcinomas. PLoS One 2014 ; 9 : e87170 (IF : 3.534, SIGAPS : B).

Puyo S, Montaudon D, Pourquier P. From old alkylating agents to new minor groove binders. Crit Rev Oncol Hematol 2014 ; 89 : 43-61 (IF : 4.046, SIGAPS : B).

Raoux M, Vacher P, Papin J, Picard A, Kostrzewa E, Devin A, Gaitan J, Limon I, Kas MJ, Magnan C, Lang J. Multilevel control of glucose homeostasis by adenylyl cyclase 8. Diabetologia 2014 ; doi: 10.1007/s00125-014-3445-z. Epub 2014 Nov 19 (IF : 6.88, SIGAPS : A).

Robert J, Le Morvan V, Giovannetti E, Peters GJ, on behalf of the PAMM Group of EORTC. On the use of pharmacogenetics in cancer treatment and clinical trials. Eur J Cancer 2014 ; 50 : 2532-43 (IF : 4.819, SIGAPS : B).

Schmitt A, Soubeyran P. New drugs for follicular lymphoma in older adults. Anticancer Agents Med Chem 2014 ; 14 : 657-64 (IF : 2.939, SIGAPS : C).

Soubeyran P, Bellera C, Goyard J, Heitz D, Curé H, Rousselot H, Albrand G, Servent V, Saint-Jean O, Van Praagh I, Kurtz JE, Périn S, Verhaeghe JL, Terret C, Desauw C, Girre V, Mertens C, Mathoulin-Pélissier S, Rainfray M. Screening for vulnerability in older cancer patients: the ONCODAGE prospective multicenter cohort study. PLoS One 2014 ; 9 : e115060 (IF : 3.534, SIGAPS : B).

Szwed M, Laroche-Clary A, Robert J, Jozwiak Z. Induction of apoptosis by doxorubicin-transferrin conjugate compared to free doxorubicin in the human leukemia cell lines. Chem Biol Interact 2014 ; 220 : 140-8 (IF : 2.982, SIGAPS : C).

Szwed M, Matusiak A, Laroche-Clary A, Robert J, Marszalek I, Jozwiak Z. Transferrin as a drug carrier: cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells. Toxicol In Vitro 2014 ; 28 : 187-97 (IF : 3.207, SIGAPS : C).

Trocoli A, Bensadoun P, Richard E, Labrunie G, Merhi F, Schläfli AM, Brigger D, Souquere S, Pierron G, Pasquet JM, Soubeyran P, Reiffers J, Ségal-Bendirdjian E, Tschan MP, Djavaheri-Mergny M. p62/SQSTM1 upregulation constitutes a survival mechanism that occurs during granulocytic differentiation of acute myeloid leukemia cells. Cell Death Differ 2014 ; 21 : 1852-61 (IF : 8.385, SIGAPS : A).

Revues générales

Morrison VA, Hamlin P, Soubeyran P, Stauder R, Wadhwa P, Aapro M, Lichtman S. Diffuse large B-cell lymphoma in the elderly : impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) Expert Position Paper. J Geriatr Oncol 2014 ; Dec 7. pii: S1879-4068(14)00357-9. doi: 10.1016/j. jgo.2014.11.004. [Epub ahead of print] : (IF : 1.146, SIGAPS : E).

Ségal-Bendirdjian E, Tschan MP, Reiffers J, Djavaheri-Mergny M. Pro-survival role of p62/SQSTM1 during ATRA-induced granulocytic differentiation of AML cells. Mol Cell Oncol 2014 ; 4 : e970066.

Editoriaux - analyses

Robert J. Ciblage de mTOR et identification de « répondeurs exceptionnels ». Bull Cancer 2014 ; 101 : 775 (IF : 0.635, SIGAPS : E).

Conférences sur invitation - Nationales

Djavaheri-Mergny M. Autophagy, cell death and differentiation in cancer cells. Autophagy & Cancer Symposium. Toulouse, 15 septembre 20104.

Conférences sur invitation - Internationales

Iggo R. Humanisation of the mouse mammary gland by selective replacement of the luminal layer with preneoplastic human cells. European Network of Breast Development and Cancer labs (ENBDC), Weggis (Suisse), May 8-10, 2014.


Vue complète des publications en cours : cliquer ici



Vue complète des publications 2013 (PDF) : cliquer ici




Faire un don


Culture et santé


Federation des CLCC